Previous 10 | Next 10 |
Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 19.4 cents per share of common stock. The dividend reflects an 8% increase over the previous quarter. The dividend will be paid on Jan. 27, 2021 ...
University of Pennsylvania scientists recognized for their contributions to the field of CAR T-cell mediated cancer immunotherapy Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD , and Michael Milone, MD, Ph.D ., as recipients of an Agi...
Agilent Technologies (A) has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-negative breast cancer ((TNBC)) for treatment with Merck's (MRK) Keytruda (pembrolizumab). The expanded use of PD-L1 IHC 22C3 pharmDx strengthens the ability ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
Announcement marks the seventh cancer type for which PD-L1 IHC 22C3 pharmDx has gained approval in the US Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-nega...
Expanding laboratory dioxin testing with the latest technology Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regul...
William Von Mueffling's 13F portfolio value increased this quarter from $11.51B to $11.96B. All positions saw minor trimming during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~28% of the 13F portfolio. For further ...
GUANGZHOU, China, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that analytical validation data of its fully-automated NGS library preparation platform, Magnis BR, will be presented a...
Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2020 financial results after the stock market closes on Monday, Nov. 23. The company will host a live webcast of its investor conference call in listen-only mode on the same day. The company will also host a...
Illumina's acquisition of Grail was received poorly - we disagree wholeheartedly with the market and see significant upside from the acquisition, which increases its addressable market by 10x. The company is dominant, with a ~70% market share, and is the global market leader in next-g...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...